GREY:ATBPF - Post by User
Comment by
themagicboxon Aug 12, 2021 4:56pm
207 Views
Post# 33698146
RE:RE:RE:Timelines...
RE:RE:RE:Timelines...The ALT happened in 3 people. Cool your jets.
Its ok you're a bad investor and there is no shame in that. And I get that you're butthurt. Learn from it instead of spreading misinformation.
Here is a list of my faviorute FUD coming out your a$$:
1- What is your confidence level that 75mg will be statistically signifigant to placebo over a two week period?
if you had watched the Wallace video you would clearly see that 75mg provided COX suppression similar to naproxen at 250mg BID
2-The issue is that they don't know how effective it is at 75mg from a WOMAC (pain relief) score perspective and if it is not as effective as Naproxen who with Arthritis is going to take it if there is no pain releif.
another variation of the same FUD
3-I don't want to rain on the 352 parade but it's not even in Phase 1 and patents on IP expire in 2032 in the U.S. Plus 346 is/was the one with hige TAM and blockbuster potential.
This has been addreessed several times when ATE takes about expanding the pipeline, its literally to extended IP protection for 352 and 340, in addition to another drug for IBD.
4-Furthermore, have you ever heard of the term "placebo-effect" for drug trials and that being one of the main reasons drug trials fail Phase 2. So here we are re-doing Phase 2 all over again....if that isn't additional risk then I don't know what is.
Yet another variation on your BS on 75mg issue you made up. Look up the PK values and cox suppression for 75mg of 346. Indeed you dont know what additional risk is.